ObjectiveMitochondrial dysfunction has been suggested as a potential cause for heart failure. Pressure overload is a common cause for heart failure. However, implementing pressure overload in mice is considered a model for compensated hypertrophy but not for heart failure. We assessed the suitability of minimally invasive transverse aortic constriction to induce heart failure in C57BL/6 mice and assessed mitochondrial biogenesis and function.MethodsMinimally invasive transverse aortic constriction was performed through a ministernotomy without intubation (minimally invasive transverse aortic constriction, n = 68; sham operation, n = 43). Hypertrophy was assessed based on heart weight/body weight ratios and histologic analyses, and contracti...
The transcription factor MEF2 is a downstream target for several hypertrophic signalling pathways in...
Background: Transverse aortic constriction (TAC) operation is used as an experimental model of left ...
The transcription factor MEF2 is a downstream target for several hypertrophic signalling pathways in...
ObjectiveMitochondrial dysfunction has been suggested as a potential cause for heart failure. Pressu...
Aims Generation of reproducible cardiac disease phenotypes in mice is instrumental for investigating...
Left ventricular pressure overload in response to aortic banding is an invaluable model for studying...
Heart failure (HF) is characterized by abnormal mitochondrial calcium (Ca2+) handling, energy failur...
Left ventricular pressure overload in response to aortic banding is an invaluable model for studying...
Heart failure (HF) is characterized by abnormal mitochondrial calcium (Ca2+) handling, energy failur...
Left ventricular pressure overload in response to aortic banding is an invaluable model for studying...
<div><p>Mineralocorticoid receptor (MR) blockade has been shown to suppress cardiac hypertrophy and ...
Aims Peroxisome proliferator-activated receptor-a (PPARa) is a nuclear receptor regulating cardiac m...
Abstract Background: The cardiac hypertrophy (CH) model for mice has been widely used, thereby prov...
Mineralocorticoid receptor (MR) blockade has been shown to suppress cardiac hypertrophy and remodeli...
Abstract Background: The cardiac hypertrophy (CH) model for mice has been widely used, thereby prov...
The transcription factor MEF2 is a downstream target for several hypertrophic signalling pathways in...
Background: Transverse aortic constriction (TAC) operation is used as an experimental model of left ...
The transcription factor MEF2 is a downstream target for several hypertrophic signalling pathways in...
ObjectiveMitochondrial dysfunction has been suggested as a potential cause for heart failure. Pressu...
Aims Generation of reproducible cardiac disease phenotypes in mice is instrumental for investigating...
Left ventricular pressure overload in response to aortic banding is an invaluable model for studying...
Heart failure (HF) is characterized by abnormal mitochondrial calcium (Ca2+) handling, energy failur...
Left ventricular pressure overload in response to aortic banding is an invaluable model for studying...
Heart failure (HF) is characterized by abnormal mitochondrial calcium (Ca2+) handling, energy failur...
Left ventricular pressure overload in response to aortic banding is an invaluable model for studying...
<div><p>Mineralocorticoid receptor (MR) blockade has been shown to suppress cardiac hypertrophy and ...
Aims Peroxisome proliferator-activated receptor-a (PPARa) is a nuclear receptor regulating cardiac m...
Abstract Background: The cardiac hypertrophy (CH) model for mice has been widely used, thereby prov...
Mineralocorticoid receptor (MR) blockade has been shown to suppress cardiac hypertrophy and remodeli...
Abstract Background: The cardiac hypertrophy (CH) model for mice has been widely used, thereby prov...
The transcription factor MEF2 is a downstream target for several hypertrophic signalling pathways in...
Background: Transverse aortic constriction (TAC) operation is used as an experimental model of left ...
The transcription factor MEF2 is a downstream target for several hypertrophic signalling pathways in...